K. Denis-Mize

发表

Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice1

D. McDonald, J. Ulmer, J. Donnelly, 2000, The Journal of Immunology.

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

D. McDonald, M. L. Mackichan, J. Ulmer, 2000, Gene Therapy.

Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles.

D. McDonald, J. Donnelly, Manmohan J. Singh, 2003, Cellular immunology.

Detection of human enteric viruses in stream water with RT-PCR and cell culture.

G. Fout, D. R. Dahling, K. Denis-Mize, 2004, Journal of water and health.

Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients.

N. Gross, H. Nelson, K. Denis-Mize, 2008, Respiratory medicine.

Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial.

E. Kerwin, N. Gross, H. Nelson, 2007, Clinical therapeutics.

Long-term safety of nebulized formoterol: Results of a twelve-month open-label clinical trial

N. Hanania, C. Fogarty, J. Donohue, 2008, Therapeutic advances in respiratory disease.

Microparticles and DNA Vaccines

J. Ulmer, J. Donnelly, Manmohan J. Singh, 2006 .

Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease

N. Hanania, I. Chaudry, D. Tashkin, 2009, Advances in therapy.

Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI*

E. R. Sutherland, G. Feldman, K. Denis-Mize, 2009 .

Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.

M. Littner, D. Tashkin, C. Andrews, 2008, Respiratory medicine.

Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A.

D. Galloway, N. Baker, K. Denis-Mize, 2000, FEMS immunology and medical microbiology.

Studies on the presentation of Pseudomonas exotoxin to the host immune system : implications for vaccine development /

K. Denis-Mize, 1999 .

Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide

E. Kerwin, N. Hanania, K. Denis-Mize, 2009, Drugs.

CARDIOVASCULAR SAFETY OF NEBULIZED FORMOTEROL IN COPD PATIENTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

N. Gross, H. Nelson, K. Denis-Mize, 2007 .

Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI.

E. R. Sutherland, G. Feldman, K. Denis-Mize, 2009, Current medical research and opinion.

Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma

A. Difrancesco, J. Gockerman, A. Levine, 2004, Clinical Cancer Research.

Recombinant Interleukin-2 Significantly Augments Activity of Rituximab in Human Tumor Xenograft Models of B-cell Non-Hodgkin Lymphoma

Yan Tang, J. Kunich, B. Jallal, 2007, Journal of immunotherapy.

Injection in Mice Their Immunogenicity After Intramuscular Distribution of DNA Vaccines Determines

D. McDonald, J. Ulmer, J. Donnelly, 2000 .

Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis

Marc Dupuis, Wendy Peters, D. McDonald, 2001, European journal of immunology.

Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways.

V. Engelhard, C. Slingluff, D. Galloway, 2000, Cellular immunology.

SAFETY AND EFFICACY OF CONCOMITANT TREATMENT WITH NEBULIZED FORMOTEROL AND TIOTROPIUM IN COPD

M. Littner, D. Tashkin, C. Andrews, 2007 .

Nebulized formoterol fumarate: Dose selection and pharmacokinetics.

E. Kerwin, N. Gross, K. Denis-Mize, 2008, Pulmonary pharmacology & therapeutics.